PURPOSE: Improvement in survival of pediatric acute lymphoblastic leukemia (ALL) has increased the attention to quality of life (QoL) . QoL is impaired during maintenance treatment, but little is known about QoL during induction therapy. Identification of patients with poor QoL during induction will provide opportunities for early interventions, and may subsequently improve future QoL. This national multi-center study aimed to assess QoL and its determinants during ALL induction treatment. METHODS: Proxy reports of the Child Health Questionnaire (CHQ) and the PedsQL cancer version were collected. Child, treatment, and parental characteristics were analyzed as potential determinants in a multiple regression model. RESULTS: One hundred thirty parents of children participated (response rate 82 %), median child age was 5.7 years and 48 % were female. QoL, as measured with the CHQ, was significantly lower than the norm, the effect sizes were large, and the differences were clinically relevant. Physical QoL was more often affected than psychosocial QoL. Regression models could be constructed for 4/ 10 CHQ scales and 6/ 8 PedsQL cancer scales, accounting for 7 to 36 % of the variance in scores. Impaired QoL was most often associated with older children, girls, and time since diagnosis. Also, father respondents seem to have a lower QoL perception compared to mother respondents although this needs to be confirmed in future research. CONCLUSIONS: Specific counseling for subsets of patients with a higher risk of low QoL during the early phases of therapy is warranted.
PURPOSE: Improvement in survival of pediatric acute lymphoblastic leukemia (ALL) has increased the attention to quality of life (QoL) . QoL is impaired during maintenance treatment, but little is known about QoL during induction therapy. Identification of patients with poor QoL during induction will provide opportunities for early interventions, and may subsequently improve future QoL. This national multi-center study aimed to assess QoL and its determinants during ALL induction treatment. METHODS: Proxy reports of the Child Health Questionnaire (CHQ) and the PedsQL cancer version were collected. Child, treatment, and parental characteristics were analyzed as potential determinants in a multiple regression model. RESULTS: One hundred thirty parents of children participated (response rate 82 %), median child age was 5.7 years and 48 % were female. QoL, as measured with the CHQ, was significantly lower than the norm, the effect sizes were large, and the differences were clinically relevant. Physical QoL was more often affected than psychosocial QoL. Regression models could be constructed for 4/ 10 CHQ scales and 6/ 8 PedsQL cancer scales, accounting for 7 to 36 % of the variance in scores. Impaired QoL was most often associated with older children, girls, and time since diagnosis. Also, father respondents seem to have a lower QoL perception compared to mother respondents although this needs to be confirmed in future research. CONCLUSIONS: Specific counseling for subsets of patients with a higher risk of low QoL during the early phases of therapy is warranted.
Authors: Lillian Sung; Rochelle Yanofsky; Robert J Klaassen; David Dix; Sheila Pritchard; Naomi Winick; Sarah Alexander; Anne Klassen Journal: Int J Cancer Date: 2011-03-01 Impact factor: 7.396
Authors: A J Janse; R J B J Gemke; C S P M Uiterwaal; I van der Tweel; J L L Kimpen; G Sinnema Journal: J Clin Epidemiol Date: 2004-07 Impact factor: 6.437
Authors: Anjo J Veerman; Willem A Kamps; Henk van den Berg; Eva van den Berg; Jos P M Bökkerink; Marrie C A Bruin; Marry M van den Heuvel-Eibrink; Carin M Korbijn; Elisabeth T Korthof; Karin van der Pal; Theo Stijnen; Margreet H van Weel Sipman; J Fransje van Weerden; Elisabeth R van Wering; Anna van der Does-van den Berg Journal: Lancet Oncol Date: 2009-09-09 Impact factor: 41.316
Authors: Machteld A G de Vries; Raphaële R L van Litsenburg; Jaap Huisman; Martha A Grootenhuis; A Birgitta Versluys; Gert Jan L Kaspers; Reinoud J B J Gemke Journal: Health Qual Life Outcomes Date: 2008-11-26 Impact factor: 3.186
Authors: Simone M Sint Nicolaas; Sasja A Schepers; Esther M M van den Bergh; Andrea W M Evers; Peter M Hoogerbrugge; Martha A Grootenhuis; Christianne M Verhaak Journal: Support Care Cancer Date: 2015-06-25 Impact factor: 3.603
Authors: Niki Rensen; Lindsay M H Steur; Sasja A Schepers; Johannes H M Merks; Annette C Moll; Martha A Grootenhuis; Gertjan J L Kaspers; Raphaële R L van Litsenburg Journal: Eur J Psychotraumatol Date: 2019-07-22
Authors: Charlotte Sleurs; Jammbe Musoro; Ali Rowsell; Michal Kicinski; Stefan Suciu; Sofia Chantziara; Corneel Coens; Madeline Pe; Pierre Missotten; Els Vandecruys; Anne Uyttebroeck; Marie-Françoise Dresse; Claire Pluchart; Alina Ferster; Claire Freycon; Jutte van der Werff Ten Bosch; Pierre-Simon Rohrlich; Yves Benoit; Anne-Sophie Darlington; Caroline Piette Journal: Cancers (Basel) Date: 2021-12-29 Impact factor: 6.639
Authors: Clarissa E Schilstra; Karen McCleary; Joanna E Fardell; Mark W Donoghoe; Emma McCormack; Rishi S Kotecha; Richard De Abreu Lourenco; Shanti Ramachandran; Ruelleyn Cockcroft; Rachel Conyers; Siobhan Cross; Luciano Dalla-Pozza; Peter Downie; Tamas Revesz; Michael Osborn; Frank Alvaro; Claire E Wakefield; Glenn M Marshall; Marion K Mateos; Toby N Trahair Journal: BMC Cancer Date: 2022-09-15 Impact factor: 4.638